The efficacy and functions of dabigatran etexilate capsules (Pradaxa)

Dabigatran etexilate (Pradaxa) is an oral anticoagulant that belongs to the direct thrombin inhibitor class. Its main ingredient is dabigatran etexilate, a reversible, highly selective thrombin inhibitor. This drug is widely used to prevent and treat thrombosis-related diseases, especially in the prevention and treatment of stroke and systemic embolism in patients with non-valvular atrial fibrillation.

The main functions and functions of dabigatran etexilate are as follows:

1.Anticoagulant effect: Dabigatran etexilate prevents the blood coagulation process by inhibiting the activity of thrombin. This is essential to prevent blood clots from forming and reduce the risk of stroke and embolism. It is particularly useful in those with non-valvular atrial fibrillation, as this arrhythmia can lead to the formation of blood clots in the atria.

2.Prevention of non-valvular atrial fibrillation: Dabigatran etexilate is widely used in patients with non-valvular atrial fibrillation to prevent the occurrence of stroke and systemic embolism. Atrial fibrillation causes blood to pool in the atria, increasing the risk of blood clots. Dabigatran etexilate reduces this risk by inhibiting a key step in blood clot formation.

3.Treatment of deep vein thrombosis and pulmonary embolism: Dabigatran etexilate is also used to treat deep vein thrombosis and pulmonary embolism, which are serious conditions related to the formation of blood clots. By stopping the clotting process, it helps reduce or eliminate blood clots that have formed, thereby improving the patient's condition.

4.Post-operative anticoagulation: In some patients who require surgery, especially those undergoing high-risk surgery such as joint replacement surgery, dabigatran etexilate can be used to prevent postoperative thrombosis.

5.Convenient oral medication: Dabigatran etexilate is an oral medication that is more convenient for patients to use and improves patient compliance compared with traditional injectable anticoagulants.

6.Reversible anticoagulant effect: The anticoagulant effect of dabigatran etexilate is reversible, which means that coagulation function can be restored by administering reversal agents when necessary. This feature increases management flexibility in emergency situations.

Despite the many advantages of dabigatran etexilate in anticoagulant therapy, there are some potential risks and cautions. For example, bleeding events may occur, so patients' coagulation needs to be closely monitored during use. In addition, for specific patient groups, such as patients with impaired renal function, caution needs to be used and dosage adjustments should be made under the supervision of a physician.

Overall, the widespread availability of dabigatran etexilate provides an effective option for those patients requiring anticoagulant therapy. However, before use, patients should receive a thorough evaluation, and the doctor will weigh the benefits and risks of the drug based on the patient's specific situation to ensure the best treatment plan.

Dabigatran etexilate capsulesIt has been launched in China and has been covered by medical insurance. Patients can purchase it domestically. Please consult the local hospital pharmacy for specific prices. The main foreign drug is the original drug of dabigatran etexilate capsules. The cheaper one is the Turkish version of the German original drug. The specification is 110mg*60 and the price is about three to four hundred. It is consistent with the ingredients and efficacy of the original drug on the domestic market.